Your browser doesn't support javascript.
loading
Does "OPTINAB" strategy ("stop-and-go") work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel-gemcitabine?
Relias, Valerie; Maloney, Antonia; Smith, Melissa H; Saif, Muhammad Wasif.
Affiliation
  • Relias V; Section of GI Cancers and Experimental Therapeutics, Tufts Cancer Center, Tufts University School of Medicine, 800 Washington Street, Boston, 02111, MA, USA.
  • Maloney A; Section of GI Cancers and Experimental Therapeutics, Tufts Cancer Center, Tufts University School of Medicine, 800 Washington Street, Boston, 02111, MA, USA.
  • Smith MH; Section of GI Cancers and Experimental Therapeutics, Tufts Cancer Center, Tufts University School of Medicine, 800 Washington Street, Boston, 02111, MA, USA.
  • Saif MW; Section of GI Cancers and Experimental Therapeutics, Tufts Cancer Center, Tufts University School of Medicine, 800 Washington Street, Boston, 02111, MA, USA. wsaif@tuftsmedicalcenter.org.
Cancer Chemother Pharmacol ; 80(2): 371-375, 2017 Aug.
Article in En | MEDLINE | ID: mdl-28664225

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Peripheral Nervous System Diseases / Albumins Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Peripheral Nervous System Diseases / Albumins Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: Germany